« Back
Home /
Palbociclib (isethionate)

Palbociclib (isethionate)

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Colorectal Cancer Breast Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	5 mg
Item no.	HY-A0065-5mg
Targets	CDK
CASRN	827022-33-3
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Palbociclib (PD 0332991) isethionate is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib isethionate has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma[1][3][4].
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	573.66
Clinical_Information	Launched
Manufacturers Research_Area	Cancer
Solubility	DMSO : 10 mg/mL (ultrasonic)
Manufacturers Target	CDK
Isoform	CDK4; CDK6
Pathway	Cell Cycle/DNA Damage
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-A0065-5mg-safety-datasheet.pdf